PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Pediatrics10.3345/cep.2021.007872022656304-311Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trialThushara Rodrigo, Samaranayake Dulani, Sumudu Nimali Seneviratne, Arjuna P. De Silva, Jerad Fernando, H. Janaka De Silva, Jayasekera, V. Pujitha Wickramasinghehttp://e-cep.org/upload/pdf/cep-2021-00787.pdf, http://e-cep.org/journal/view.php?doi=10.3345/cep.2021.00787, http://e-cep.org/upload/pdf/cep-2021-00787.pdf
Clinical Liver Disease10.1002/cld.63201214117-118Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exerciseAngelo H. Paredes, Dawn M. Torres, Stephen A. Harrisonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.63, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.63/fullpdf
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2020.02.0052020185A28Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitishttps://api.elsevier.com/content/article/PII:S1542356520301683?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1542356520301683?httpAccept=text/plain
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.66/fullpdf
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2017.05.02920171581144-1147Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic SteatofibrosisZobair M. Younossihttps://api.elsevier.com/content/article/PII:S1542356517306092?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1542356517306092?httpAccept=text/plain
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2019.04.018201917101950-1953PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic SteatohepatitisMaya Balakrishnan, Rohit Loombahttps://api.elsevier.com/content/article/PII:S1542356519303787?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1542356519303787?httpAccept=text/plain
Clinical Liver Disease10.1002/cld.9742020155195-199Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated CirrhosisTatyana Kushner, John Cafardihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.974, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cld.974, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.974
Clinical Liver Disease10.1002/cld.716201811498-104Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisErin Cleveland, Andrew Bandy, Lisa B. VanWagnerhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.716, https://onlinelibrary.wiley.com/doi/full/10.1002/cld.716
Lifestyle Medicine10.1007/978-3-319-24687-1_292016321-332Nonalcoholic Fatty Liver Disease and SteatohepatitisErin M. McCarthy, Mary E. Rinellahttp://link.springer.com/content/pdf/10.1007/978-3-319-24687-1_29
Clinics in Liver Disease10.1016/j.cld.2017.08.00120182211-10Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisZobair M. Younossi, Linda Henry, Haley Bush, Alita Mishrahttps://api.elsevier.com/content/article/PII:S1089326117300624?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1089326117300624?httpAccept=text/plain